Other specified hereditary hemolytic anemias
ICD-10 D58.8 is a billable code used to indicate a diagnosis of other specified hereditary hemolytic anemias.
D58.8 refers to a category of hereditary hemolytic anemias that do not fall under more specific classifications. Hemolytic anemias are characterized by the premature destruction of red blood cells, leading to anemia. This condition can arise from various genetic factors, including enzyme deficiencies such as glucose-6-phosphate dehydrogenase (G6PD) deficiency, which can cause hemolysis under oxidative stress. Other hereditary conditions include thalassemias, which are caused by mutations affecting hemoglobin production, and sickle cell disease, where abnormal hemoglobin leads to distorted red blood cells that can obstruct blood flow. The genetic basis of these conditions often requires detailed family history and genetic testing for accurate diagnosis. Patients may present with symptoms such as fatigue, pallor, jaundice, and splenomegaly. Management typically involves addressing the underlying cause, which may include blood transfusions, folic acid supplementation, or more advanced therapies like hydroxyurea for sickle cell disease. Understanding the specific type of hemolytic anemia is crucial for effective treatment and management.
Comprehensive lab results, genetic testing, and family history.
Diagnosis and management of hereditary hemolytic anemias, including G6PD deficiency and thalassemia.
Ensure accurate coding based on specific genetic tests and patient history.
Detailed genetic testing reports and family pedigree charts.
Counseling patients on hereditary risks and implications of hemolytic anemias.
Documentation must reflect the genetic basis of the condition for accurate coding.
Used to evaluate anemia and hemolysis.
Document the reason for the CBC and any relevant symptoms.
Hematology specialists should ensure correlation with clinical findings.
Coding D58.8 accurately reflects the presence of hereditary hemolytic anemias, which is crucial for appropriate management and treatment planning.
